Last reviewed · How we verify
NCT04719052: MED4Youth
Mediterranean Enriched Diet for Tackling Youth Obesity
NA trial testing Diet and behavioural intervention in Obesity, Adolescent in 240 participants. Completed in 28 November 2023.
9 October 2023
Quick facts
| Lead sponsor | Fundació Eurecat |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 240 |
| Start date | 25 May 2021 |
| Primary completion | 9 October 2023 |
| Estimated completion | 28 November 2023 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Diet and behavioural intervention
- Diet and behavioural intervention
Conditions studied
- Obesity, Adolescent — all drugs for Obesity, Adolescent →
- Lifestyle, Healthy — all drugs for Lifestyle, Healthy →
- Diet, Healthy — all drugs for Diet, Healthy →
- Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →
Sponsor
Fundació Eurecat
Who can join
Adults 13 to 17, any sex, with Obesity, Adolescent or Lifestyle, Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The prevalence of obesity is one of the main public health problems worldwide, reaching 18% among young people between 5 and 19 years of age in 2016. One possibility of effective treatment can be the Mediterranean diet (MD). Therefore, it is proposed to carry out a nutritional intervention based on this diet to more effectively reduce obesity in adolescents. The main purpose of this multicentre study is to assess whether an energy-restricted Mediterranean-style diet (MD) intervention including healthy products from the Mediterranean basin (mixed nuts, pomegranate and hummus) and sourdough bread is more effective against obesity and associated CVD risk factors than a conventional low-fat diet carrying out a multicentre nutritional and clinical intervention study specifically targeting obese/overweight adolescents (13-17y) from different Mediterranean countries; all combined with an educational web-application designed to encourage healthy behaviours. It is a multicenter, randomized, controlled intervention study conducted with adolescents with obesity/overweight ≥90 percentile who do not suffer from any chronic disease. 240 subjects will be recruited from three Mediterranean countries: Italy (Parma), Portugal (Coimbra) and Spain (Reus), specifically 80 participants per country, 40 adolescents as an intervention group and 40 as a control group, in Reus. The intervention study is scheduled to begin in January 2021. The intervention group will receive a diet based on the characteristics of MD, and will be reinforced with satisfying and healthy Mediterranean foods such as sourdough bread (2 servings of 50-60g / day), squeezed pomegranate (4 servings of 200ml / week), hummus/chickpeas (2 portions of chickpeas of 150-200g / week, one in hummus format) and mixed nuts (4 servings of 30g / week); and the control group will receive a recommended diet based on the consumption of low-fat foods. A caloric restriction of 20% of the total energy requirements will be applied to both groups in adolescents with BMI ≥95 percentile (obesity) and a caloric restriction \<20% of the total energy requirements will be applied in adolescents with BMI ≥90 to \<95th percentile according to overweight (gender/age / physical activity). The diet will be applied for 4 months in both groups. Adolescents from both groups will be given a motivational interview and will be provided with an educational website that will be used during the intervention, through which they will learn.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Study Protocol of a Multicenter Randomized Controlled Trial to Tackle Obesity through a Mediterranean Diet vs. a Traditional Low-Fat Diet in Adolescents: The MED4Youth Study.
Boqué N, Tarro L, Rosi A, Torrell H, et al · · 2021 · cited 5× · PMID 34062731 · DOI 10.3390/ijerph18094841
Verify or expand the search:
- PubMed search for NCT04719052
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity, Adolescent
Currently open trials in the same condition.
- NCT06920862 — Multi-Modal Digital Interventions for Adolescent Weight Management · NA · recruiting
- NCT06822387 — Health Without Barriers/Salud Sin Barreras- Northern Colorado · NA · recruiting
- NCT06309121 — Effects of the Postbiotic Blend ABB C3 on Adiposity and Glucose Metabolism in Children and Adolescents · NA · active not recruiting
- NCT05982847 — National Blood Pressure Screening in Children to Improve Paediatric Healthcare in South Africa · recruiting
- NCT06515288 — Nutrition Goes to School: a School-based Nutrition Intervention to Promote Healthy Eating Behaviour Among Adolescents · NA · recruiting
Other Fundació Eurecat trials
Trials by the same sponsor.
- NCT06774911 — Evaluation of Amino Acids Bioavailability in a Food Product Based on a Vegetable Protein Combination · NA · completed
- NCT06365320 — Association Between Training Load and Lactate and Other Metabolites Analyzed by Metabolomic and Proteomic Techniques · NA · completed
- NCT07436936 — OPTIPROT, Targeted Precision Nutrition for Protein Needs in Ageing · completed
- NCT06377631 — Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdomi · NA · completed
- NCT06289140 — Oral Bioavailability of a New Formulation of Pterostilbene Cocrystal in Comparison With Its Free Form (BIOPTERO2) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04719052 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundació Eurecat
- Last refreshed: 30 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04719052.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing